MedTrace Logo

Effect of Chlorogenic Acids on the Human Vasculature

NCT03520452 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-01-15

No results posted yet for this study

Summary

This study evaluates effects of different doses of chlorogenic acids on vascular health.

Conditions

  • Endothelial Dysfunction

Interventions

OTHER

Green coffee extract

Reconstituted in water and given to subjects

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Leslie Tan · Société des Produits Nestlé (SPN)

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-14
Primary Completion
2018-11-07
Completion
2018-12-20

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03520452 on ClinicalTrials.gov